IgM antibodies against dsDNA in SLE

Area of Science:

• Immunology
• Nephrology
• Rheumatology

Background:

• Immunoglobulin G (IgG) antibodies against double-stranded DNA (dsDNA) are implicated in the kidney damage seen in systemic lupus erythematosus (SLE) glomerulonephritis.
• Conversely, glomerulonephritis is uncommon in SLE patients with immunoglobulin M (IgM) antibodies against dsDNA, suggesting a protective role for IgM.

Purpose of the Study:

• To investigate the potential protective effect of IgM antibodies against dsDNA in the context of lupus nephritis.
• To explore the therapeutic implications of IgM antibodies in treating SLE-related kidney disease.

Main Methods:

• Analysis of associations between antibody isotypes (IgM vs. IgG) against dsDNA and glomerulonephritis incidence in SLE patients.
• Utilizing murine models of SLE to assess the impact of IgM deficiency and administration of IgM monoclonal antibodies against dsDNA on renal pathology.
• Investigating the role of IgM in the clearance of immune complexes.

Main Results:

• Absence of secreted IgM in murine SLE models correlated with more severe glomerulonephritis.
• Treatment with a murine IgM monoclonal antibody against dsDNA successfully prevented renal damage in lupus-prone mice.
• IgM antibodies appear to enhance the clearance of pathogenic immune complexes.

Conclusions:

• IgM antibodies against dsDNA exhibit a protective effect against lupus nephritis.
• These findings suggest that IgM antibodies against dsDNA could represent a novel therapeutic strategy for human lupus nephritis.